Simplex Trading’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
Other funds holding CADL
ACA
SVCM
Simplex Trading's CADL Position: Q3 2026 in Review
Simplex Trading increased its Candel Therapeutics (CADL) stake by 50% in Q3 2026, buying an estimated $9.8K and bringing the position to 2,631 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6772.
Simplex Trading first reported a position in CADL in Q2 2024 and has held it in 7 quarters since. The position peaked at $158K in Q3 2024. 141 funds tracked by Wall St. Rank hold CADL as of Q3 2026.
- Simplex Trading held 2,631 shares of Candel Therapeutics worth $27.5K as of Q3 2026.
- Simplex Trading bought 882 Candel Therapeutics shares in Q3 2026, an estimated $9.8K.
- Candel Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #6772 holding.
- Simplex Trading first reported a position in Candel Therapeutics in Q2 2024 and has held it in 7 quarters since.
- Simplex Trading's Candel Therapeutics position peaked at $158K in Q3 2024.
- 141 funds tracked by Wall St. Rank held Candel Therapeutics as of Q3 2026.
Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.